Port Capital LLC purchased a new position in shares of IDEX Corporation (NYSE:IEX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 108,202 shares of the industrial products company’s stock, valued at approximately $24,556,000. Port Capital LLC owned 0.15% of IDEX as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the business. Empowered Funds LLC increased its stake in IDEX by 3.4% in the first quarter. Empowered Funds LLC now owns 1,646 shares of the industrial products company’s stock valued at $298,000 after purchasing an additional 54 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in IDEX by 4.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 1,446 shares of the industrial products company’s stock valued at $274,000 after buying an additional 56 shares during the period. Evolve Private Wealth LLC grew its holdings in IDEX by 2.8% in the 1st quarter. Evolve Private Wealth LLC now owns 2,125 shares of the industrial products company’s stock valued at $403,000 after buying an additional 58 shares during the period. Sanctuary Advisors LLC increased its stake in shares of IDEX by 2.6% during the 1st quarter. Sanctuary Advisors LLC now owns 2,443 shares of the industrial products company’s stock valued at $463,000 after acquiring an additional 62 shares during the last quarter. Finally, Mackenzie Financial Corp increased its stake in shares of IDEX by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 2,562 shares of the industrial products company’s stock valued at $458,000 after acquiring an additional 70 shares during the last quarter. Institutional investors and hedge funds own 97.96% of the company’s stock.
IDEX News Summary
Here are the key news stories impacting IDEX this week:
- Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
- Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
- Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
- Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
- Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
- Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on IDEX
IDEX Price Performance
IEX opened at $234.91 on Thursday. IDEX Corporation has a 52-week low of $158.19 and a 52-week high of $243.80. The company has a 50 day moving average of $228.47 and a two-hundred day moving average of $213.48. The company has a market cap of $17.32 billion, a P/E ratio of 33.80, a P/E/G ratio of 2.17 and a beta of 0.98. The company has a quick ratio of 2.15, a current ratio of 3.05 and a debt-to-equity ratio of 0.46.
IDEX (NYSE:IEX – Get Free Report) last issued its earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. The business had revenue of $920.60 million for the quarter, compared to the consensus estimate of $905.38 million. IDEX had a net margin of 14.49% and a return on equity of 15.69%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.07 EPS. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. On average, analysts expect that IDEX Corporation will post 8.82 earnings per share for the current year.
IDEX Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were given a $0.73 dividend. The ex-dividend date of this dividend was Monday, July 6th. This represents a $2.92 annualized dividend and a yield of 1.2%. IDEX’s dividend payout ratio (DPR) is 42.01%.
Insider Activity at IDEX
In other IDEX news, CAO Lisa M. Anderson sold 385 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total transaction of $91,857.15. Following the transaction, the chief accounting officer owned 4,327 shares in the company, valued at $1,032,378.93. The trade was a 8.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.50% of the stock is currently owned by corporate insiders.
IDEX Profile
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Recommended Stories
- Five stocks we like better than IDEX
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding IEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IDEX Corporation (NYSE:IEX – Free Report).
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
